MENU
+Compare
AXGN
Stock ticker: NASDAQ
AS OF
Jun 12 closing price
Price
$10.04
Change
-$0.13 (-1.28%)
Capitalization
348.67M

AXGN Axogen Forecast, Technical & Fundamental Analysis

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair... Show more

AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AXGN with price predictions
Jun 12, 2025

AXGN in upward trend: price expected to rise as it breaks its lower Bollinger Band on June 11, 2025

AXGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where AXGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on May 30, 2025. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AXGN as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for AXGN moved below the 200-day moving average on May 30, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AXGN entered a downward trend on June 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.582) is normal, around the industry mean (24.242). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.139) is also within normal values, averaging (42.497).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AXGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AXGN is expected to report earnings to fall 400.00% to 5 cents per share on August 06

Axogen AXGN Stock Earnings Reports
Q2'25
Est.
$0.06
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.11
The last earnings report on May 08 showed earnings per share of -1 cents, missing the estimate of 1 cents. With 550.35K shares outstanding, the current market capitalization sits at 348.67M.
A.I.Advisor
published Dividends

AXGN paid dividends on February 12, 2010

Axogen AXGN Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of February 12, 2010, and an ex-dividend date of January 27, 2010. Read more...
A.I. Advisor
published General Information

General Information

a provider of products and technologies for peripheral nerve reconstruction and regeneration

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13631 Progress Boulevard
Phone
+1 386 462-6800
Employees
428
Web
https://www.axogeninc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSMCX9.86N/A
N/A
Invesco Small Cap Value C
SCVIX34.85N/A
N/A
Allspring Small Company Value Admin
PMDHX18.57N/A
N/A
Principal Small-MidCap Dividend Inc R6
RRSVX14.45N/A
N/A
RBC Small Cap Value R6
DHIYX19.61N/A
N/A
Diamond Hill International Y

AXGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with VMD. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then VMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-1.28%
VMD - AXGN
44%
Loosely correlated
+0.44%
TCMD - AXGN
43%
Loosely correlated
-0.85%
TMDX - AXGN
38%
Loosely correlated
+0.12%
XRAY - AXGN
36%
Loosely correlated
-0.62%
MXCT - AXGN
35%
Loosely correlated
-1.30%
More